Financials Shanghai MicroPort EP MedTech Co., Ltd.

Equities

688351

CNE100005PG9

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
22.41 CNY +2.99% Intraday chart for Shanghai MicroPort EP MedTech Co., Ltd. +6.77% -12.63%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 12,457 12,071 10,546 - -
Enterprise Value (EV) 1 12,457 11,814 9,907 9,820 10,546
P/E ratio 3,781 x 2,120 x 288 x 139 x 78.9 x
Yield - - - - -
Capitalization / Revenue 47.9 x 36.7 x 22.5 x 16 x 11.6 x
EV / Revenue 47.9 x 35.9 x 21.1 x 14.9 x 11.6 x
EV / EBITDA 707 x 376 x 185 x 92.9 x 60.6 x
EV / FCF -302 x -148 x -300 x 526 x 166 x
FCF Yield -0.33% -0.68% -0.33% 0.19% 0.6%
Price to Book 7.43 x 7.16 x 6.12 x 5.85 x 5.45 x
Nbr of stocks (in thousands) 470,600 470,600 470,600 - -
Reference price 2 26.47 25.65 22.41 22.41 22.41
Announcement Date 2/17/23 2/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 260.3 329.2 468.7 659 911.4
EBITDA 1 - 17.62 31.38 53.42 105.8 173.9
EBIT 1 - 3.026 7.646 39.03 86.32 149
Operating Margin - 1.16% 2.32% 8.33% 13.1% 16.35%
Earnings before Tax (EBT) 1 - 2.972 5.61 37.6 83.85 147.8
Net income 1 -11.97 2.972 5.689 36.19 77.13 134.2
Net margin - 1.14% 1.73% 7.72% 11.7% 14.73%
EPS 2 -0.0299 0.007000 0.0121 0.0778 0.1608 0.2840
Free Cash Flow 1 - -41.31 -79.9 -33 18.67 63.5
FCF margin - -15.87% -24.27% -7.04% 2.83% 6.97%
FCF Conversion (EBITDA) - - - - 17.65% 36.51%
FCF Conversion (Net income) - - - - 24.2% 47.32%
Dividend per Share - - - - - -
Announcement Date 8/10/22 2/17/23 2/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 89.15
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 4.169
Net margin 4.68%
EPS 2 0.008900
Dividend per Share -
Announcement Date 4/24/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - 256 639 726 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - -41.3 -79.9 -33 18.7 63.5
ROE (net income / shareholders' equity) - 0.31% 0.34% 2.1% 4.32% 6.99%
ROA (Net income/ Total Assets) - 0.24% 0.31% 1.66% 3.48% 5.5%
Assets 1 - 1,229 1,808 2,182 2,216 2,440
Book Value Per Share 2 - 3.560 3.580 3.660 3.830 4.110
Cash Flow per Share 2 - -0.0200 -0.0800 0.0300 0.1100 0.2000
Capex 1 - 31.9 41.9 85.1 82.5 84.4
Capex / Sales - 12.26% 12.74% 18.17% 12.53% 9.26%
Announcement Date 8/10/22 2/17/23 2/27/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
22.41 CNY
Average target price
29.14 CNY
Spread / Average Target
+30.05%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688351 Stock
  4. Financials Shanghai MicroPort EP MedTech Co., Ltd.